These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 30464142)
1. Correlation between Pathological Findings and the Usefulness of Clinical Guidelines for the Treatment of ANCA-Positive RPGN: A Retrospective Analysis. Yamada T; Kashiwagi T; Shimizu A; Tsuruoka S J Nippon Med Sch; 2018; 85(5):259-264. PubMed ID: 30464142 [TBL] [Abstract][Full Text] [Related]
2. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan. Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007 [TBL] [Abstract][Full Text] [Related]
3. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children]. Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis]. Ito C; Ando Y; Akimoto T; Kusano E; Asano Y Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918 [TBL] [Abstract][Full Text] [Related]
5. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Hedger N; Stevens J; Drey N; Walker S; Roderick P Nephrol Dial Transplant; 2000 Oct; 15(10):1593-9. PubMed ID: 11007827 [TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of severe ANCA-associated RPGN with high-dose IVIg therapy]. Gomada M; Akamatsu A Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):79-83. PubMed ID: 15058108 [TBL] [Abstract][Full Text] [Related]
7. Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group. Aydin Z; Turkmen K; Dede F; Yasar E; Ozturk S; Aydin M; Tatar E; Sahin G; Manga G; Oto O; Sumnu A; Eroglu E; Dincer T; Dursun B; Eren N; Sevinc M; Guzel FB; Yalin S; Kutlay S; Apaydin S; Berktas HB; Kazan S; Dheir H; Bora F; Basturk T; Sahin I Clin Exp Nephrol; 2021 Feb; 25(2):173-183. PubMed ID: 33040246 [TBL] [Abstract][Full Text] [Related]
8. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies]. Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246 [TBL] [Abstract][Full Text] [Related]
9. [A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia]. Yamazaki K; Kanehira K; Inaba Y; Shimizu J; Sugiyama N Nihon Jinzo Gakkai Shi; 2012; 54(8):1203-8. PubMed ID: 23387284 [TBL] [Abstract][Full Text] [Related]
14. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN. Yamagata K; Hirayama K; Mase K; Yamaguchi N; Kobayashi M; Takahashi H; Koyama A J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406 [TBL] [Abstract][Full Text] [Related]
15. [A case of MPO ANCA associated glomerulonephritis with interstitial pneumonitis complicated with lung tuberculosis and pericarditis]. Takahashi K; Suda S; Takayama M; Deguchi F; Matsuda O; Tachibana K; Yoshimura A Nihon Jinzo Gakkai Shi; 2000 Oct; 42(7):591-6. PubMed ID: 11155703 [TBL] [Abstract][Full Text] [Related]
16. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy. Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422 [TBL] [Abstract][Full Text] [Related]
17. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223 [TBL] [Abstract][Full Text] [Related]
18. [A case of hepatitis C virus-associated glomerulonephropathy presenting with MPO-ANCA-positive rapidly progressive glomerulonephritis]. Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Goto T Nihon Jinzo Gakkai Shi; 2000 May; 42(4):353-8. PubMed ID: 10897595 [TBL] [Abstract][Full Text] [Related]
19. [Idiopathic rapidly progressive glomerulonephritis and small vessel vasculitis]. Zhou F; Zhang Y; Zhao M Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):603-6. PubMed ID: 10436970 [TBL] [Abstract][Full Text] [Related]
20. [Case of immune complex crescentic glomerulonephritis with consistently high titers of MPO-ANCA for 6 years]. Ayada M; Matsuo T; Takada S; Kusaura T; Suda S; Okado T; Mori Y; Tajima M; Kuwahara M; Kobayashi Y; Tsukamoto Y; Sasaki S Nihon Jinzo Gakkai Shi; 2007; 49(5):511-6. PubMed ID: 17695814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]